Towards Healthcare Research & Consulting
U.S. Contraceptive Market
Updated Date: 23 June 2026   |   Report Code: 6801
[email protected] +1 804-441-9344
Download Sample Order Now

U.S. Contraceptive Market Size, Share and Industry Trends 2035

According to Shivani Zoting, who specializes in women's health, reproductive healthcare, and pharmaceutical market intelligence, with 5+ years of experience in market research and industry analysis. Her research indicates that the U.S. contraceptive market is set to grow from USD 11.52 billion in 2026 to USD 20.66 billion by 2035, driven by expanding access to family planning solutions and continued innovation across hormonal and long-acting reversible contraceptives (LARC). She identifies hormonal contraceptives, female-focused products, retail pharmacies, and clinics as the leading market segments, while online pharmacies and homecare settings demonstrate the strongest growth potential. Her analysis also highlights the competitive presence of Bayer AG, Pfizer Inc., HRA Pharma, Agile Therapeutics, and Piramal Healthcare & Sun Pharma, alongside increasing investment in non-hormonal and male contraceptive technologies across the U.S. market.

Last Updated : 23 June 2026 Category: Pharmaceuticals Insight Code: 6801 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global U.S. Contraceptive Market Analysis, By Product Type
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global U.S. Contraceptive Market Analysis, By Gender
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global U.S. Contraceptive Market Analysis, By Age Group
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global U.S. Contraceptive Market Analysis, By Distribution Channel
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global U.S. Contraceptive Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America U.S. Contraceptive Market Analysis
  • North America U.S. Contraceptive Market Analysis, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America U.S. Contraceptive Market Analysis, By Gender, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America U.S. Contraceptive Market Analysis, By Age Group, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America U.S. Contraceptive Market Analysis, By Distribution Channel, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America U.S. Contraceptive Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U.S. U.S. Contraceptive Market Analysis
    • U.S. U.S. Contraceptive Market Analysis, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. U.S. Contraceptive Market Analysis, By Gender, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. U.S. Contraceptive Market Analysis, By Age Group, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. U.S. Contraceptive Market Analysis, By Distribution Channel, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Product Type
      • By Gender
      • By Age Group
      • By Distribution Channel
    • Strategies of Key Players
    • Insight From the Horse’s Mouth

 

  • Company Profiles
    • Agile Therapeutics, Inc.
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Piramal Healthcare & Sun Pharma 
    • HRA Pharma
    • Bayer AG
    • Pfizer Inc.

FAQ's

Answer : The U.S. contraceptive market currently in 2026 records USD 11.52 billion and is anticipated to grow to USD 20.66 billion by 2035, advancing at a CAGR of 6.7% from 2026 to 2035.

Answer : National Institutes of Health, FDA, WHO, PIB, CDC.

Answer : Major trends include Growth of non-hormonal contraceptives, Increased R&D in male contraception, Rising adoption of dual-protection methods.
Any Questions

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar